US Stock MarketDetailed Quotes

ADC Therapeutics (ADCT)

Watchlist

3.480
+0.050+1.46%

Close May 13 16:00 ET

3.480
0.0000.00%

Post 20:01 ET

442.63MMarket Cap-3.59P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ADC Therapeutics (ADCT) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

47.26%-29.71M

-14.00%-141.17M

-42.43%-31.12M

-18.32%-29.63M

26.66%-24.09M

-27.76%-56.33M

-4.34%-123.84M

30.92%-21.85M

31.71%-25.04M

6.12%-32.85M

Net income from continuing operations

14.60%-32.97M

9.64%-142.62M

79.14%-6.41M

6.83%-40.97M

-55.01%-56.65M

17.17%-38.6M

34.25%-157.85M

63.86%-30.73M

5.90%-43.97M

25.30%-36.54M

Operating gains losses

---2.23M

----

-64.25%1.54M

--0

-145.55%-578K

-318.61%-1.63M

Depreciation and amortization

-75.16%114K

-42.74%1.88M

-85.75%113K

-84.79%122K

41.05%1.18M

-45.55%459K

0.28%3.28M

-6.38%793K

-9.38%802K

3.20%838K

Deferred tax

----

--0

Other non cash items

-15.62%6.46M

-47.66%9.04M

-241.01%-13.79M

5.49%7.76M

5.37%7.42M

10.49%7.66M

-0.14%17.28M

-136.57%-4.04M

7.26%7.36M

-33.69%7.04M

Change In working capital

83.04%-5.01M

-762.70%-25.36M

-215.48%-11.58M

-95.41%392K

418.47%15.35M

-197.44%-29.52M

-91.36%3.83M

47.41%10.03M

1,944.71%8.54M

-195.98%-4.82M

-Change in receivables

83.15%-1.93M

-284.22%-8.79M

-266.63%-6.19M

360.03%3.27M

1,648.28%5.58M

-673.68%-11.45M

-90.02%4.77M

192.87%3.71M

-146.55%-1.26M

69.68%319K

-Change in inventory

105.23%16K

36.13%-2.38M

69.51%-853K

41.36%-516K

-236.29%-706K

46.13%-306K

34.73%-3.73M

-1,775.45%-2.8M

74.71%-880K

125.24%518K

-Change in prepaid assets

-47.95%2.01M

453.58%5.23M

----

827.56%3.19M

1,018.10%3.86M

---1.48M

----

---439K

-Change in payables and accrued expense

69.44%-7.06M

-221.00%-16.46M

-80.61%2.91M

-120.02%-2.09M

182.80%5.82M

-382.09%-23.09M

223.99%13.6M

75.56%14.98M

423.00%10.43M

-2,151.60%-7.03M

-Change in other current assets

----

89.91%-46K

-364.98%-5.45M

349.35%5.55M

-2,333.33%-146K

--0

-106.09%-456K

96.75%2.06M

-269.33%-2.23M

-100.13%-6K

-Change in other current liabilities

32.95%1.96M

67.20%-2.91M

-12.13%-7.23M

-23.42%1.23M

-11.19%1.61M

125.12%1.47M

-256.53%-8.88M

-712.35%-6.45M

-27.93%1.61M

-33.06%1.81M

Cash from discontinued investing activities

Operating cash flow

47.26%-29.71M

-14.00%-141.17M

-42.43%-31.12M

-18.32%-29.63M

26.66%-24.09M

-27.76%-56.33M

-4.34%-123.84M

30.92%-21.85M

31.71%-25.04M

6.12%-32.85M

Investing cash flow

Cash flow from continuing investing activities

87.88%-32K

145.56%395K

832.22%659K

50.28%-264K

73.04%-867K

72.48%-90K

67.32%-216K

97.52%-30K

Net PPE purchase and sale

87.88%-32K

145.56%395K

832.22%659K

--0

50.28%-264K

73.04%-867K

72.48%-90K

67.32%-216K

97.52%-30K

Cash from discontinued investing activities

Investing cash flow

87.88%-32K

145.56%395K

832.22%659K

--0

50.28%-264K

73.04%-867K

72.48%-90K

67.32%-216K

97.52%-30K

Financing cash flow

Cash flow from continuing financing activities

-315.13%-583K

55.53%150.95M

5,197.23%57.09M

77.47%-198K

-4.98%93.78M

-23.88%271K

31.38%97.05M

-111,900.00%-1.12M

-351.86%-879K

35.01%98.7M

Net common stock issuance

---20K

42.60%86.28M

--43.52M

60.90%-479K

--43.24M

--0

--60.51M

--0

---1.23M

----

Proceeds from stock option exercised by employees

-24.35%205K

75.48%66.18M

34,390.70%14.83M

-18.79%281K

37.41%50.79M

-23.88%271K

4,778.53%37.71M

4,400.00%43K

-0.86%346K

--36.97M

Net other financing activities

---768K

-30.18%-1.51M

---1.26M

--0

----

-101.59%-1.16M

----

Cash from discontinued financing activities

Financing cash flow

-315.13%-583K

55.53%150.95M

5,197.23%57.09M

77.47%-198K

-4.98%93.78M

-23.88%271K

31.38%97.05M

-111,900.00%-1.12M

-351.86%-879K

35.01%98.7M

Net cash flow

Beginning cash position

4.17%261.34M

-9.95%250.87M

-14.41%234.74M

-11.85%264.56M

-16.90%194.7M

-9.95%250.87M

-14.66%278.6M

-11.64%274.27M

-13.64%300.12M

-24.56%234.29M

Current changes in cash

46.16%-30.33M

136.77%10.17M

215.45%26.63M

-14.12%-29.83M

5.89%69.7M

-27.24%-56.33M

42.43%-27.65M

27.84%-23.06M

29.33%-26.14M

78.37%65.82M

Effect of exchange rate changes

-103.11%-5K

467.47%305K

92.71%-25K

-97.94%6K

1,258.33%163K

474.42%161K

-145.11%-83K

-325.66%-343K

346.61%291K

-80.33%12K

End cash Position

18.65%231.01M

4.17%261.34M

-14.41%234.74M

-11.85%264.56M

-16.90%194.7M

-9.95%250.87M

-11.64%274.27M

-13.64%300.12M

Free cash flow

47.45%-29.74M

-13.42%-141.44M

-41.84%-31.12M

-17.30%-29.63M

26.73%-24.09M

-26.83%-56.6M

-2.30%-124.7M

31.35%-21.94M

32.34%-25.26M

9.19%-32.88M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	47.26%-29.71M	-14.00%-141.17M	-42.43%-31.12M	-18.32%-29.63M	26.66%-24.09M	-27.76%-56.33M	-4.34%-123.84M	30.92%-21.85M	31.71%-25.04M	6.12%-32.85M
Net income from continuing operations	14.60%-32.97M	9.64%-142.62M	79.14%-6.41M	6.83%-40.97M	-55.01%-56.65M	17.17%-38.6M	34.25%-157.85M	63.86%-30.73M	5.90%-43.97M	25.30%-36.54M
Operating gains losses	---2.23M	----	----	----	----	----	-64.25%1.54M	--0	-145.55%-578K	-318.61%-1.63M
Depreciation and amortization	-75.16%114K	-42.74%1.88M	-85.75%113K	-84.79%122K	41.05%1.18M	-45.55%459K	0.28%3.28M	-6.38%793K	-9.38%802K	3.20%838K
Deferred tax	----	----	----	----	----	----	--0	--0	--0	--0
Other non cash items	-15.62%6.46M	-47.66%9.04M	-241.01%-13.79M	5.49%7.76M	5.37%7.42M	10.49%7.66M	-0.14%17.28M	-136.57%-4.04M	7.26%7.36M	-33.69%7.04M
Change In working capital	83.04%-5.01M	-762.70%-25.36M	-215.48%-11.58M	-95.41%392K	418.47%15.35M	-197.44%-29.52M	-91.36%3.83M	47.41%10.03M	1,944.71%8.54M	-195.98%-4.82M
-Change in receivables	83.15%-1.93M	-284.22%-8.79M	-266.63%-6.19M	360.03%3.27M	1,648.28%5.58M	-673.68%-11.45M	-90.02%4.77M	192.87%3.71M	-146.55%-1.26M	69.68%319K
-Change in inventory	105.23%16K	36.13%-2.38M	69.51%-853K	41.36%-516K	-236.29%-706K	46.13%-306K	34.73%-3.73M	-1,775.45%-2.8M	74.71%-880K	125.24%518K
-Change in prepaid assets	-47.95%2.01M	453.58%5.23M	----	----	827.56%3.19M	1,018.10%3.86M	---1.48M	----	----	---439K
-Change in payables and accrued expense	69.44%-7.06M	-221.00%-16.46M	-80.61%2.91M	-120.02%-2.09M	182.80%5.82M	-382.09%-23.09M	223.99%13.6M	75.56%14.98M	423.00%10.43M	-2,151.60%-7.03M
-Change in other current assets	----	89.91%-46K	-364.98%-5.45M	349.35%5.55M	-2,333.33%-146K	--0	-106.09%-456K	96.75%2.06M	-269.33%-2.23M	-100.13%-6K
-Change in other current liabilities	32.95%1.96M	67.20%-2.91M	-12.13%-7.23M	-23.42%1.23M	-11.19%1.61M	125.12%1.47M	-256.53%-8.88M	-712.35%-6.45M	-27.93%1.61M	-33.06%1.81M
Cash from discontinued investing activities
Operating cash flow	47.26%-29.71M	-14.00%-141.17M	-42.43%-31.12M	-18.32%-29.63M	26.66%-24.09M	-27.76%-56.33M	-4.34%-123.84M	30.92%-21.85M	31.71%-25.04M	6.12%-32.85M
Investing cash flow
Cash flow from continuing investing activities	87.88%-32K	145.56%395K	832.22%659K	0	0	50.28%-264K	73.04%-867K	72.48%-90K	67.32%-216K	97.52%-30K
Net PPE purchase and sale	87.88%-32K	145.56%395K	832.22%659K	--0	--0	50.28%-264K	73.04%-867K	72.48%-90K	67.32%-216K	97.52%-30K
Cash from discontinued investing activities
Investing cash flow	87.88%-32K	145.56%395K	832.22%659K	--0	--0	50.28%-264K	73.04%-867K	72.48%-90K	67.32%-216K	97.52%-30K
Financing cash flow
Cash flow from continuing financing activities	-315.13%-583K	55.53%150.95M	5,197.23%57.09M	77.47%-198K	-4.98%93.78M	-23.88%271K	31.38%97.05M	-111,900.00%-1.12M	-351.86%-879K	35.01%98.7M
Net common stock issuance	---20K	42.60%86.28M	--43.52M	60.90%-479K	--43.24M	--0	--60.51M	--0	---1.23M	----
Proceeds from stock option exercised by employees	-24.35%205K	75.48%66.18M	34,390.70%14.83M	-18.79%281K	37.41%50.79M	-23.88%271K	4,778.53%37.71M	4,400.00%43K	-0.86%346K	--36.97M
Net other financing activities	---768K	-30.18%-1.51M	---1.26M	--0	----	----	-101.59%-1.16M	----	----	----
Cash from discontinued financing activities
Financing cash flow	-315.13%-583K	55.53%150.95M	5,197.23%57.09M	77.47%-198K	-4.98%93.78M	-23.88%271K	31.38%97.05M	-111,900.00%-1.12M	-351.86%-879K	35.01%98.7M
Net cash flow
Beginning cash position	4.17%261.34M	-9.95%250.87M	-14.41%234.74M	-11.85%264.56M	-16.90%194.7M	-9.95%250.87M	-14.66%278.6M	-11.64%274.27M	-13.64%300.12M	-24.56%234.29M
Current changes in cash	46.16%-30.33M	136.77%10.17M	215.45%26.63M	-14.12%-29.83M	5.89%69.7M	-27.24%-56.33M	42.43%-27.65M	27.84%-23.06M	29.33%-26.14M	78.37%65.82M
Effect of exchange rate changes	-103.11%-5K	467.47%305K	92.71%-25K	-97.94%6K	1,258.33%163K	474.42%161K	-145.11%-83K	-325.66%-343K	346.61%291K	-80.33%12K
End cash Position	18.65%231.01M	4.17%261.34M	4.17%261.34M	-14.41%234.74M	-11.85%264.56M	-16.90%194.7M	-9.95%250.87M	-9.95%250.87M	-11.64%274.27M	-13.64%300.12M
Free cash flow	47.45%-29.74M	-13.42%-141.44M	-41.84%-31.12M	-17.30%-29.63M	26.73%-24.09M	-26.83%-56.6M	-2.30%-124.7M	31.35%-21.94M	32.34%-25.26M	9.19%-32.88M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm